Phosgene derivatives maker VanDeMark changes private equity owners
21:28 PM | April 23, 2019 | Vincent Valk
The company was previously owned by three private equity firms: Verus Investment Partners, Brightwood Capital, and Prudential Capital.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.